Myocarditis Up After Second Dose of mRNA-1273 Versus BNT162b2
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — The rates of myocarditis and pericarditis are increased after receipt of the second dose of mRNA-1273 versus BNT162b2, according to a study published in the Nov. 15 issue of the Journal of the American Colle…
Learn MoreMyocarditis Up After Second Dose of mRNA-1273 Versus BNT162b2
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — The rates of myocarditis and pericarditis are increased after receipt of the second dose of mRNA-1273 versus BNT162b2, according to a study published in the Nov. 15 issue of the Journal of the American Colle…
Learn MoreEn medio de un aumento en los casos de VSR, hay esperanzas de una nueva vacuna
LUNES, 7 de noviembre de 2022 (HealthDay News) — Los bebés y los niños enfermos con el VSR están inundando los consultorios y los hospitales pediátricos de todo Estados Unidos, debido a un aumento temprano en el virus común de la infancia este año.Pe…
Learn MoreSecond, Third COVID-19 Vaccine May Up Relapse in Glomerular Disease
MONDAY, Nov. 7, 2022 (HealthDay News) — Exposure to a second or third dose of COVID-19 vaccine is associated with an increased risk for relapse for adults with glomerular disease, according to a study published online Nov. 3 in the Journal of the Ame…
Learn MoreUn estudio de Pfizer encuentra un gran aumento en la inmunidad con el refuerzo contra la COVID
VIERNES, 4 de noviembre de 2022 (HealthDay News) — Es probable que ponerse un refuerzo actualizado contra la COVID-19 aumente la protección de forma sustancial, según un nuevo estudio, publicado por la compañía farmacéutica Pfizer el viernes.La notic…
Learn MoreCOVID-19 mRNA Vaccines Tied to Higher Risk for Myocarditis, Pericarditis
MONDAY, Nov. 7, 2022 (HealthDay News) — A higher incidence of myocarditis or pericarditis occurs after COVID-19 vaccination, according to a review published online Sept. 25 in the American Journal of Preventive Medicine.Juan Gao, from Anhui Medical U…
Learn MoreAmid a Surge in RSV Cases, Hopes for a New Vaccine
MONDAY, Nov. 7, 2022 (HealthDay News) — Infants and children sick with RSV are flooding pediatricians’ offices and children’s hospitals across the United States, due to an early surge of the common childhood virus this year.But within one or two “sic…
Learn MorePfizer Study Reveals Big Rise in Immunity From COVID-19 Booster
FRIDAY, Nov. 4, 2022 (HealthDay News) — Getting an updated booster for COVID-19 is likely to boost protection substantially, according to a new study released by drug company Pfizer on Friday.The news affirms a decision by the U.S. Food and Drug Admi…
Learn MorePfizer Study Finds Big Rise in Immunity From COVID Booster
FRIDAY, Nov. 4, 2022 (HealthDay News) — Getting an updated booster for COVID-19 is likely to boost protection substantially, according to a new study released by drug company Pfizer on Friday.The news affirms a decision by the U.S. Food and Drug Admi…
Learn MoreRoutine Vaccination Coverage Decreased in 2021 Worldwide
THURSDAY, Nov. 3, 2022 (HealthDay News) — Routine vaccination coverage decreased worldwide in 2021, according to research published in the Nov. 4 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Audr…
Learn More